Evaluation of the Galileo Pathogen Solution Next-Generation Sequencing Pipeline for the Detection and Quantitation of DNA Viruses in Immunocompromised Hosts
Clinical Virology Symposium 2019 – WorkshopPart of a workshop presented at the Clinical Virology Symposium on May 6th, 2019 by Dr. Benjamin Pinsky, Associate Professor of Pathology and Medicine at Stanford Health Care and Stanford Children’s Health.
Dr. Pinsky outlines the current state of clinical virology testing for immunocompromised hosts and presents data from a single institution retrospective study of the Galileo™-Transplant NGS Pipeline for detection and quantitation of DNA viruses conducted at Stanford Health Care.
In this presentation you will learn:
- Why deploying NGS-based metagenomics (mNGS) into your laboratory makes sense
- How mNGS compares with and improves upon qPCR as a detection platform
- How to validate mNGS-based assays in your laboratory
- How mNGS identified additional viruses missed by conventional qPCR in over 50% of samples
Workshop Video (18:51 minutes):
Workshop Slide Deck (17 slides):
For research use only. Not for use in diagnostics or diagnostic procedures.
